Grifols SA reported Q1 2026 revenues of €1.7 billion, up 3.3% from the previous year, with a net profit increase of 21.9% to €73 million; this event was reported on May 7, 2026. The solid growth was mainly driven by its Biopharma division, which saw a 6.8% increase on a constant currency basis.